These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6768064

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
    Shenai S, Rodrigues C, Mehta A.
    Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
    [Abstract] [Full Text] [Related]

  • 23. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI, Grishina TA, Karpenko OL, Safonova SG, Grishina TD.
    Probl Tuberk; 1995 Jan; (4):37-40. PubMed ID: 7567869
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis.
    Fattorini L, Gennaro R, Zanetti M, Tan D, Brunori L, Giannoni F, Pardini M, Orefici G.
    Peptides; 2004 Jul; 25(7):1075-7. PubMed ID: 15245864
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Biochemical study on the host response to tuberculous infection. IV. Influences of isoniazid, streptomycin, nicotinamide, and cortisone.
    Toida I, Ando F, Yamamoto S.
    Am Rev Respir Dis; 1968 Sep; 98(3):424-8. PubMed ID: 4299758
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Combined effect of histones and antibiotics in vitro and in vivo. Antibacterial effect of histone fractions of the calf thymus in combination with streptomycin and tubazid].
    Ashmarin IP, Zhdan-Pushkina SM, Vishnevskiĭ BI.
    Antibiotiki; 1972 Mar; 17(3):266-9. PubMed ID: 5039536
    [No Abstract] [Full Text] [Related]

  • 31. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS, Jamieson F, Chedore P, Haddad A, Vernich L.
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [Abstract] [Full Text] [Related]

  • 32. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS, Gupta S, Lal S.
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
    Laszlo A, Rahman M, Espinal M, Raviglione M, WHO/IUATLD Network of Supranational Reference Laboratories.
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):748-56. PubMed ID: 12234129
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
    Kobayashi I, Abe C, Mitarai S.
    Kekkaku; 2006 Feb; 81(2):57-62. PubMed ID: 16529006
    [Abstract] [Full Text] [Related]

  • 39. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M, Garrouche A, Jerray M, Hayouni A, Maalel K, Klabi N.
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.